CDSCO monthly lab alert
CDSCO NSQ alert, April 2025: 196 drug batches flagged
By Blacklisted editorial team· Published 20 May 2025· Updated 20 Sep 2026· Source: CDSCO NSQ portal
In its April 2025 alert, the Central Drugs Standard Control Organisation listed 196 drug batches that failed quality tests, 74 at central laboratories and 122 at state drug-testing laboratories, from 127 manufacturers across 121 products. The most common failure was dissolution, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1, Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ), Sodium Chloride Injection IP 0.9 %w/v.
196
Batches flagged
74 / 122
Central / state labs
Dissolution
Top reason
127
Manufacturers
Batches per month, last 12 alerts
May 2024Apr 2025 · 196
Full list of NSQ batches, April 2025
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| Z&D Syrup (Zinc Gluconate Oral Solution 20mg) | XSZE24005Mfg 2024-08 · Exp 2026-01 | Hema Laboratories Pvt LtdUttarakhand | Sample does not conform to Label Claim with respect to content of Elemental Zinc in Zinc GluconateLabelling | DTL MaduraiState lab |
| Winocin 500 (Paracetamol tablets IP 500 mg) | JT-2405719Mfg 2024-05 · Exp 2026-10 | Jineka Healthcare Pvt. LtdUttarakhand | The sample does not conform to standard quality in respect of the test for "Dissolution" performed.Dissolution | SDTL Agartala, TripuraState lab |
| WORMKILL-PLUS (Albendazole & Ivermectin Oral Suspension) | SRVL-24003Mfg 2024-06 · Exp 2026-05 | SPAS RemediesHimachal Pradesh | Assay for Albendazole and IvermectinAssay | State Lab KarnatakaState lab |
| Teneligliptin & Metformin Hydrochloride (Sustained Release) Tablets IP (Teglisure-M 500) | AOT244-00BMfg 2024-03 · Exp 2026-02 | Astonea Labs Pvt. LtdHaryana | Assay/content of TeneligliptinAssay | CDL KolkataCDSCO lab |
| Telmisartan Tab IP 40 mg | D0004/25-26Mfg ? · Exp ? | Kerala Medical services Corporation LimitedKerala | The sample does not conform to IP standards with respect to descriptive part for tabletsOther | DTL ThiruvananthapuramState lab |
| Telmisartan I.P. 40 mg, Amlodipine Besylate I.P. 5 mg Tablets | ST 211Mfg 2024-04 · Exp 2026-03 | Soham Healhcare INCGujarat | "Dissolution" (Telmisartan and Amlodipine) and "Assay/ content of Telmisartan and Amlodipine"Assay | CDTL MumbaiCDSCO lab |
| Telmisartan & Hydrochlorothiazide Tablets IP (Telmijack-H) | T-20560Mfg 2024-03 · Exp 2026-02 | Jackson Laboratories Pvt. Ltd | "Related substances and Assay of Hydrochlorothiazi de"Assay | CDTL MumbaiCDSCO lab |
| Telmisartan & Amlodipine Tablets IP (XTEL-AM) | BBT240427AMfg 2024-05 · Exp 2026-04 | Biomax Biotechnics (P) Ltd 261Haryana | The sample does not conform to the claim as per IP 2022 in respect to Dissolution Test of AmlodipineDissolution | DTL BaddiState lab |
| Telmisartan & Amlodipine Tablets IP | UGT24G06AMfg 2024-10 · Exp 2026-09 | Unigrow PharmaceuticalsHimachal Pradesh | It fails the tests for ?Assay? of Amlodipine and ?Dissolution? as specified in the Laboratory Protocol as per IPAssay | DTL ThiruvananthapuramState lab |
| Telivi-H 40 (Telmisartan & Hydrochorothiazide Tablets IP | BLT23348Mfg 2023-06 · Exp 2025-05 | BRIT Lifescience a GMP Certified Company) Sainwala kaula WataHimachal Pradesh | 1. The content of Telmisartan and Hydrochlorothiazide in the sample is less (i.e. 83.13% and 79.44%of the labelled amount respectively) than I.P. limits. 2. The sample does not comply with I.P. Requirements for "Dissolution Test" for Telemisartan and Hydrochlorothiazide.Dissolution | CDTL MumbaiCDSCO lab |
| Tab Telmisartan IP 40 mg | GTM18Mfg 2024-06 · Exp 2026-05 | Super Formulation Pvt Ltd | It fails the test ?Dissolution? as per IP, specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab |
| Synclov-625 Tablets (Amoxycillin & Potassium Clavulanate Tablets IP) | MICTAB-2120Mfg 2025-01 · Exp 2026-06 | Micro FormulationsHimachal Pradesh | Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate Tablets with respect to the content of Clavulanic Acid in Potassium Clavulanate Diluted Dissolution for Clavulanic Acid and toDissolution | DTL ChennaiState lab |
| Sulphamethoxazole and Trimethoprim Tablets IP | MT386Mfg 2023-10 · Exp 2026-09 | Mayasha LifesciencesHimachal Pradesh | Dissolution of Sulphamethoxazol eDissolution | RDTL ChandigarhCDSCO lab |
| Sulbactam Sodium Sterile I.P./USP. | 23051901Mfg 2023-05 · Exp 2026-04 | Reyoung Pharmaceutical Co. Ltd | "Identification and Assay/Content of Sulbactam SodiumAssay | RDTL GuwahatiCDSCO lab |
| Sulbactam Sodium Sterile I.P./USP. | 23051806Mfg 2023-05 · Exp 2026-04 | Reyoung Pharmaceutical Co. Ltd | Identification and Assay/Content of Sulbactam SodiumAssay | RDTL GuwahatiCDSCO lab |
| Sulbactam Sodium Sterile I.P./USP. | 23051903Mfg 2023-05 · Exp 2026-04 | Reyoung Pharmaceutical Co. Ltd | Identification and Assay/Content of Sulbactam SodiumAssay | RDTL GuwahatiCDSCO lab |
| Sulbactam Sodium Sterile I.P./USP. | 23051902Mfg 2023-05 · Exp 2026-04 | Reyoung Pharmaceutical Co. Ltd | Identification and Assay/Content of Sulbactam SodiumAssay | RDTL GuwahatiCDSCO lab |
| Sulbactam Sodium Sterile I.P./USP | 23051904Mfg 2023-05 · Exp 2026-04 | Reyoung Pharmaceutical Co. Ltd | Identification and Assay/Content of Sulbactam SodiumAssay | RDTL GuwahatiCDSCO lab |
| Sucrapolis-O Suspension | CSDL24368Mfg 2024-10 · Exp 2026-09 | CSD LifesciencesHimachal Pradesh | sample does not conform to label claim with respect to the content of OxetacaineLabelling | DTL ChennaiState lab |
| Sucralfate & Oxetacaine Suspension (Rabeflux Suspension) | RBLS-02501Mfg 2025-01 · Exp 2026-12 | Tidal Laboratories Pvt. Ltd | Identification, Assay of Sucralfate and Assay of OxetacaineAssay | CDL KolkataCDSCO lab |
| Spoorthi Aloegramflour Soap | 6Mfg 2024-06 · Exp 2027-05 | Spoorthi Herbals No.:299Karnataka | Test for Matter insoluble in Alcohol onlyOther | State Lab KarnatakaState lab |
| Softuss-D (Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup) | DL2501013BMfg 2025-01 · Exp 2026-12 | Indorama Health Care Pvt LtdHaryana | Sample does not conform to IP specification for label claim with respect to the content of Phenylephrine HydrochlorideLabelling | DTL ChennaiState lab |
| Sodium Chloride Injection IP 0.9 %w/v | LV4983Mfg 2024-11 · Exp 2026-10 | Captab BiotecHimachal Pradesh | Bacterial endotoxins and SterilitySterility | RDTL ChandigarhCDSCO lab |
| Sodium Chloride Injection IP 0.9 %w/v | LV4979Mfg 2024-11 · Exp 2026-10 | Captab BiotecHimachal Pradesh | Bacterial endotoxins and SterilitySterility | RDTL ChandigarhCDSCO lab |
| Sodium Chloride Injection IP 0.9 %w/v | LV4987Mfg 2024-11 · Exp 2026-10 | Captab BiotecHimachal Pradesh | Bacterial endotoxins and SterilitySterility | RDTL ChandigarhCDSCO lab |
| Sodium Chloride Injection IP 0.9 %w/v | LV4984Mfg 2024-11 · Exp 2026-10 | Captab BiotecHimachal Pradesh | Bacterial endotoxins and SterilitySterility | RDTL ChandigarhCDSCO lab |
| Sodium Chloride Injection IP 0.9 %w/v | LV4985Mfg 2024-11 · Exp 2026-10 | Captab BiotecHimachal Pradesh | Bacterial endotoxins and SterilitySterility | RDTL ChandigarhCDSCO lab |
| Sodium Chloride Injection IP 0.9 %w/v | LV4982Mfg 2024-11 · Exp 2026-10 | Captab BiotecHimachal Pradesh | Bacterial endotoxins and SterilitySterility | RDTL ChandigarhCDSCO lab |
| Sodium Chloride Injection IP 0.9 %w/v | LV4978Mfg 2024-11 · Exp 2026-10 | Captab BiotecHimachal Pradesh | Bacterial endotoxins and SterilitySterility | RDTL ChandigarhCDSCO lab |
| Sodium Chloride Injection IP 0.9 %w/v | LV4988Mfg 2024-11 · Exp 2026-10 | Captab BiotecHimachal Pradesh | Particulate matter, Bacterial endotoxins and SterilitySterility | RDTL ChandigarhCDSCO lab |
| Sodium Chloride Injection IP (0.9% W/v) NS | 4HB01401Mfg 2024-05 · Exp 2027-04 | Aishwarya LifesciencesHimachal Pradesh | Test for SterilitySterility | State Lab KarnatakaState lab |
| Ronnin 500mg Tablets (Azithromycin Tablets IP 500mg) | PPTC082Mfg 2023-11 · Exp 2026-10 | Pratima Pharmaceuticals G.No. 56/3Maharashtra | The sample does not give IP identification test for the presence of Azithromycin. The sample is declared as spurious vide section 17-B(d) of the Drugs and Cosmetics Act, 1940 and Rules, 1945 thereunderIdentification | State Lab MaharashtraState lab |
| Rifampicin, Isoniazid and Ethmbutol Hydrochloride Tablets IP | TR-820008Mfg 2024-07 · Exp 2026-06 | Centurion Remedies Pvt. LtdGujarat | Assay of RifampicinAssay | CDL KolkataCDSCO lab |
| Restomol 650 (Paracetamol Tablets IP 650 mg) | K1224079Mfg 2024-12 · Exp 2027-11 | Kaushik Therapeutics (P) LtdTamil Nadu | It fails the test for ?Dissolution? as per IP as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab |
| Rabeprazole Sodium Injection IP | MD23H19Mfg 2023-08 · Exp 2025-07 | Martin & Brown Bio SciencesHimachal Pradesh | pH, Particulate matter, Clarity of Solution, Assay of Rabeprazole Sodium and DescriptionAssay | CDL KolkataCDSCO lab |
| Proxtl 100 DT | PXT123F02Mfg 2023-03 · Exp 2025-05 | INDU Drugs Pvt Ltd.5-5- 35/278Telangana | The sample does not comply with IP requirements for Dissolution test.Dissolution | CDTL MumbaiCDSCO lab |
| Progaba Gel (Lidocaine Hydrochloride & Gabapentin Gel) | PSWAB66Mfg 2024-06 · Exp 2025-11 | Pure & Cure Healthcare Pvt LtdUttarakhand | Sample does not conform to Label claim with respect to the content of GabapentinLabelling | DTL MaduraiState lab |
| Povigin (Povidone Iodine Ointment USP 5%w/w) | PZ-2414Mfg 2024-09 · Exp 2026-08 | GP Glister Pharmaceutical | Sample does not conform to USP specification for Povidone- Iodine Ointment with respect to the content of Available Iodine in Povidone- IodineOther | DTL ChennaiState lab |
| Polergy (Levocetizine Tablets IP 5mg) | 43037Mfg 2023-07 · Exp 2025-06 | M/.s Ronak Life care Pvt Ltd | All tablets received for analysis shows light brown coloured spots all over the surface of the tablets when observed in normal daylight with unaided eyes.Description | CDTL MumbaiCDSCO lab |
| Pioglitazone Hydrochloride Tablets (GLITO 15) | D40292Mfg 2024-05 · Exp 2027-04 | Medley Pharmaceuticals LtdDaman & Diu | "Dissolution"Dissolution | CDTL MumbaiCDSCO lab |
| Phytorab-DSR Capsules | GC 41481Mfg 2023-06 · Exp 2025-05 | J.M. Laboratories Village BhanatHimachal Pradesh | The content of rabeprazole sodium in the sample is less (i.e. 55.00% of the labelled amount) than the permissible limitsLabelling | CDTL MumbaiCDSCO lab |
| Petben (Benzoyl peroxide shampoo 2.5%) | 678585Mfg 2024-03 · Exp 2026-02 | Hidustan Antibitics LtdHimachal Pradesh | Sample does not conform to lebel claim with respect to description of shampooDescription | DTL MaduraiState lab |
| Parasev 500 Tablets(Paracetamol Tablets IP 500mg) | CHT23725Mfg 2024-03 · Exp 2026-02 | Cureza Healthcare Pvt Ltd. A.B Road | The tablets does not comply for description as, the tablets shows uneven light brown coloured spots on the surface of almost all the tablets.Description | State Lab MaharashtraState lab |
| Paracetamol, Phenylephrine HCL & Cetrizine HCL Suspension | OKOL-009Mfg 2024-07 · Exp 2026-06 | Laborate Pharmaceuticals India Ltd. (Unit0II) #31 | The sample does not conform to claim as per Patent and Proprietary in respect of the assay of Phenylephrine Hydrochloride.Assay | DTL BaddiState lab |
| Paracetamol Tablets IP 650 mg | PCT24034Mfg 2024-02 · Exp 2026-01 | Vivek Pharmachem (India) LtdRajasthan | Test for Dissolution? and ?DescriptionDissolution | State Lab KarnatakaState lab |
| Paracetamol Tablets IP 500 mg | PAK-517Mfg 2023-05 · Exp 2026-04 | Healer?s Lab Unit IIHimachal Pradesh | It fails the test for ?Dissolution? as per IP as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab |
| Paracetamol Tablets IP (Pacel-650) | RPTC-182Mfg 2025-01 · Exp 2027-12 | Chennai Oscar Bio Pharmaceuticals Pvt. LtdTamil Nadu | Does not comply with respect to test for Dissolution.Dissolution | State Lab PuducherryState lab |
| Paracetamol Tab IP 500 mg | PAK-558Mfg 2023-09 · Exp 2026-08 | Healer?s Lab Unit IIHimachal Pradesh | It fails the test ?Dissolution? as per IP , as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab |
| Paracetamol Tab IP 500 mg | PAK-524Mfg 2023-05 · Exp 2026-04 | Healer?s Lab Unit IIHimachal Pradesh | It fails the test ?Dissolution? as per IP specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab |
| Paracetamol Tab IP 500 mg | D 0001/25-26Mfg ? · Exp ? | Kerala Medical services Corporation LimitedKerala | It fails the tests dissolution as per IP specified in the Laboratory ProtocolDissolution | DTL ThiruvananthapuramState lab |
| Pantozor Tablets (Pantoprazole Sodium Tablets IP) | UTBO25AMfg 2025-02 · Exp 2027-01 | Haustus Biotech Pvt Ltd | Sample does not conform to IP specification for Pantoprazole Tablets with respect to Dissolution in Buffer stageDissolution | DTL ChennaiState lab |
| Pantoprazole Gastro- Resistant Tablets IP 40 mg. | MT240578Mfg 2024-08 · Exp 2026-07 | Mancare Laboratories Pvt. LtdUttarakhand | Dissolution in Buffer StageDissolution | CDL KolkataCDSCO lab |
| Pantonis-40 (Pantoprazole Sodium Gastro Resistant Tab IP) | JMT-2407371Mfg 2024-07 · Exp 2026-06 | JMM LaboratoriesHimachal Pradesh | It fails the test ?Dissolution? as per IP, as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25019Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 29.69 mg per bolus (74.225%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25018Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | The content of Oxfendazole found to be 883.42 mg per bolus (88.342%) against labelled claim of 1000 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25038Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | 1. Description. 2. The Content of Ivermectin found to be 34.73 mg per bolus (86.825%) against labelled claim of 40 mg per bolus.Description | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25025Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 28.57 mg per bolus (71.425%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25034Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 34.91 mg per bolus (87.275%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25033Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 26.66 mg per bolus (66.65%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25032Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 30.19 mg per bolus (75.475%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25031Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | 1. The content of Ivermectin found to be 32.52 mg per bolus (81.30%) against labelled claim of 40 mg per bolus.2. The Content of Oxfendazole found to be 880.01 mg per bolus (88.001%) against labelled claim of 1000 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25037Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | 1. The content of Oxfendazole found to be mg per bolus. 2. The Content of Ivermectin found to be 28.220 mg per bolus (70.55%) 877.69 mg per bolus (87.769%) against labelled claim of 1000Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25041Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 33.19 mg per bolus (82.975%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25035Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 25.17 mg per bolus (62.925%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25036Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 28.66 mg per bolus (71.65%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25024Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 33.069 mg per bolus (82.672%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25029Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 33.29 mg per bolus (83.225%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25028Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be labelled claim of 40 mg per bolus. 31.82 mg per bolus (79.55%) againstLabelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25027Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 31.68 mg per bolus (79.20%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25026Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 33.055 mg per bolus (82.637%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25030Mfg 2025-01 · Exp 2026-12 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 31.66 mg per bolus (79.15%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxcarbazepine Tablets IP 300 mg (OXCARBAJAJ 300) | OXB02I24Mfg 2024-09 · Exp 2026-08 | Bajaj Healthcare Ltd. R.S. No. 1818Gujarat | DissolutionDissolution | CDL KolkataCDSCO lab |
| Opivas 10 tablets | 23C-T465Mfg 2023-06 · Exp 2025-05 | Orison Pharma International KhariHimachal Pradesh | The sample does not comply with IP requirements for Dissolution test.Dissolution | CDTL MumbaiCDSCO lab |
| Opirin-75 Tablets (Aspirin Tablets IP 75mg) | 23G-T1526Mfg 2023-10 · Exp 2025-09 | Orison Pharma International KhariHimachal Pradesh | The sample does not comply for description as, almost all the tablets are brittle in nature with rough surface.Description | State Lab MaharashtraState lab |
| Opirin-75 Tablets (Aspirin Tablets IP 75mg) | 23K-T2727Mfg 2024-02 · Exp 2026-01 | Orison Pharma International KhariHimachal Pradesh | The sample does not comply for description as, the tablets shows uneven light brown coloured spots on the surface of almost all the tablets.Description | State Lab MaharashtraState lab |
| Ondansetron Tablets IP 4 mg | ONTB-06Mfg 2024-09 · Exp 2026-08 | Nestor Pharmaceuticals LimitedHaryana | It fails the test for ?Dissolution? as per IP as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab |
| Ondansetron Oral Solution I.P. 2mg/5ml | ONES-1004Mfg 2024-09 · Exp 2026-08 | Wings BiotechHimachal Pradesh | Related SusbtancesOther | CDL KolkataCDSCO lab |
| Ondansentron Tablets IP 4mg | PS39AB06Mfg 2023-06 · Exp 2025-05 | Pure & Cure Healthcare Pvt LtdUttarakhand | The sample does not comply with IP requirements for Dissolution testDissolution | CDTL MumbaiCDSCO lab |
| Omeprazole Capsules IP 20mg | HCN423FMfg 2024-06 · Exp 2026-05 | Himalaya Meditek Pvt LtdUttarakhand | Sample does not conform to IP specification with respect to Uniformity of weightUniformity of weight/content | DTL MaduraiState lab |
| Ofloxacin & Ornidazole Tablets IP (200 mg +500 mg) (Floxo OZ) | TAH-231704Mfg 2023-09 · Exp 2025-08 | Prochem Pharmaceuticals Pvt. LtdUttarakhand | DescriptionDescription | State Lab KarnatakaState lab |
| Nitrobi-CR 2.6(Nitroglycerin Controlled Release Tablets 2.6mg) | JT-2312229Mfg 2023-12 · Exp 2025-11 | Jeneka Healthcaere Pvt LtdUttarakhand | Sample does not conform to Label Claim with respect to the content of Nitroglycerine in DilutedLabelling | DTL MaduraiState lab |
| Nimesulide & Paracetamol Tablets (Somu Gold) | TTX0093Mfg 2024-01 · Exp 2026-12 | Pro-pharma Care Pvt. LtdUttarakhand | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Nimesulide & Paracetamol Bolus (Vet.) (Nip-UP Bolus) | NPB-23221Mfg 2024-02 · Exp 2026-01 | Akme BiotecUttarakhand | Disintegration TestDisintegration | State Lab KarnatakaState lab |
| Nicocred-10 (Nicorandil Tablets 10 mg) | SGT- 241195Mfg 2024-08 · Exp 2026-07 | SB Life Sciences Pvt LtdHimachal Pradesh | It fails the tests ?Dissolution? and ?Assay? as per IP , specified in the laboratory protocolAssay | DTL ThiruvananthapuramState lab |
| Neem tulsi face wash | APN612Mfg 2024-08 · Exp 2026-08 | Orgello Herbal Care Vill. BehrewalaHimachal Pradesh | The sample does not comply with IS 14648: 2011 (Second Revision) Reaffirmed 2021 Requirements for Microbiological Examination test for Neem Tulsi Face washOther | CDTL MumbaiCDSCO lab |
| Nebivolol Tablets IP | KMNB 24002Mfg 2024-10 · Exp 2026-09 | Ravian Life Sciences Pvt LtdUttarakhand | It fails the test for ?Dissolution? as per IP, as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab |
| Mupropet (Mupirocin Ointment IP 2%w/w) | DG2436Mfg 2024-07 · Exp 2025-12 | Arius Formulations Pvt Ltd | Sample does not conform to IP specification for Mupirocin Ointment with respect to the content of MupirocinOther | DTL ChennaiState lab |
| Moxivin-CV 625 (Amoxycillin and Potassium Calvulnate Tablets IP) | VMIT2404Mfg 2024-10 · Exp 2026-09 | Vertex Pharma ChemicalsPuducherry | The Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate Tablets with respect to Identification of Potassium Clavulanate, Uniformity of weight and content of Amoxycillin in Amoxycillin Trihydrate and Clavulanic Acid in Potassium Clavulanate (Deemed to be spurious).Identification | DTL MaduraiState lab |
| Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP(Moncube LC) | FDMC-588Mfg 2024-07 · Exp 2026-06 | Firstmed Therapeutics Pvt Ltd | For the received sample Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP (Moncube LC) ,Presence of Spots was observed which should not be presentOther | State Lab PuducherryState lab |
| Merocet (Cetirizine Hydrochloride Syrup) | 1124192Mfg 2024-11 · Exp 2026-10 | Kite Formulation | Sample does not conform to IP specification with respect to the PH.pH | DTL MaduraiState lab |
| Mamaearth Vitamin C daily glow light moisturising cream | AM4J160Mfg 2024-10 · Exp 2026-10 | VA Life sciences | The sample does not conform to Cosmetics Rules 2020 for the standards of cosmetics. It fails the test for the content of ?Mercury? in finished cosmetic products as specified in the Laboratoty Protocol.Other | DTL ThiruvananthapuramState lab |
| Lulimark Creams, Luliconazole Cream 1% | 92447Mfg 2024-09 · Exp 2026-08 | Forever LifeScience Pvt.Ltd. 74/DGujarat | Misbranded However, the designation "IP"in conjunction with the official title Luliconazole Cream was not mentioned on the label of the drug product as an indication that it purports to comply with IP standards. Hence, drug under Section 17 of the Drugs and Cosmetics Act, 1940 as it is not labeled in the prescribed manner. The drug Product Luliconazole Cream is official, i.e., it is included in the current edition of the Indian Pharamacopoeia (IP- 2022). As required under the Second Schedule of the Drugs and Cosmetics Act, 1940, the said drug Product shall mandatorily comply with the standards set out in the Indian Pharmacopoeia.Misbranded | State Lab Drugs Control Laboratory, TelanganaState lab |
| Losartan Potassium 50mg & Hydrochlorthiazide 12.5mg Tablets | LMT251666Mfg 2025-02 · Exp 2027-01 | Life Max Cancer LaboratoriesUttarakhand | Dissolution Test: The Dissolution of Losartan Potassium and Hydrochlorthiazide does not complies within the Prescribed limit of not less than Q value i.e. 70% of labelled claim as stated in I.P 2022.Dissolution | State Drugs Laboratory, PunjabState lab |
| Lidocaine Hydrochloride and Gabapentin Gel (Gabaneuron Gel) | PWBBO7Mfg 2024-06 · Exp 2025-11 | Pure & Cure Healthcare Pvt LtdUttarakhand | Sample does not conform to lebel claim with respect to the content of GabapentinOther | DTL MaduraiState lab |
| Levetiracetam Tablets IP 500 mg | LMT241488Mfg 2024-12 · Exp 2026-11 | Life Max Cancer Laboratories Plot No. 106 & 106AUttarakhand | DissolutionDissolution | CDTL IndoreCDSCO lab |
| Levamisole & Oxyclozanide Bolus Vet. (Wormizole Bolus) | EMVB-24162Mfg 2024-10 · Exp 2026-09 | Events CorporationHimachal Pradesh | Disintegration testDisintegration | RDTL ChandigarhCDSCO lab |
| Lelet-M Syrup (Montelukast Sodium and levocetirizine hydrochloride syrup) | LLMS-063Mfg 2024-04 · Exp 2026-03 | IOSIS Remedies pvt ltdHimachal Pradesh | sample does not conform to label claim with respect to content of Montelukast in Montelukast sodiumLabelling | DTL MaduraiState lab |
| Labetalol Hydrochloride Tablets IP 100 mg | UGT231341Mfg 2023-10 · Exp 2025-09 | Unimarck Healthcare LtdUttarakhand | Test For Assay(Content) of Labetalol HydrochlorideAssay | Government of NCT of DelhiState lab |
| L-Histact-M Tablets | 24DT122AMfg 2026-06 · Exp 2027-05 | Kashmik Formuation Pvt LtdGujarat | Sample does not conform to IP Specification for Levocetrizine Hydrocloride and Montelukast Tablets with respect to the contect of Levocetrizine Hydrochloride and Montelukast in Montelukast in Montelukast sodium.Other | DTL MaduraiState lab |
| Koplyco Syrup | TL-6337Mfg 2023-06 · Exp 2023-05 | Ticoma Pharmacia E-17 Industrial Focal Point DebrabassiPunjab | 1. Content of vitamin B1 in the sample is less (i.e. 71.10% of the labelled amount) than the permissible limits. 2. Content of the Vitamin B2 in the sample is less (i.e. 72.74%) of the labelled amount) than the permissible limits.Labelling | CDTL MumbaiCDSCO lab |
| Kivoral Forte(Trypsin and Chymotrypsin Tablets) | SB-4242Mfg 2023-07 · Exp 2025-06 | Sano-Cito Thereapeutics Inc Vill LoharanHimachal Pradesh | The enzymatic activity of trypsin chymotrypsin in the sample is less (i.e. 40.52%) of the labelled amount) than the permissible limits.Labelling | CDTL MumbaiCDSCO lab |
| Ketoconazole Tablets I.P. 200mg | GT301737Mfg 2024-03 · Exp 2026-02 | Gnosis Pharmaceuticals Pvt. LtdHimachal Pradesh | Description onlyDescription | State Lab KarnatakaState lab |
| Kelan Soap(Ketoconazole Meidcated Soap) | 8091Mfg 2026-10 · Exp 2026-09 | Vimson DermaGujarat | sample does not conform to label claim with respect to the content of KetoconazoleLabelling | DTL MaduraiState lab |
| Iron Sucrose Injection USP 100mg/5ml | 24RS15Mfg 2024-12 · Exp 2026-11 | SAI Parenterals LimitedTelangana | pH and AlkalinitypH | CDL KolkataCDSCO lab |
| Iron Sucrose Injection USP 100mg/5ml | 24RS03Mfg 2024-01 · Exp 2025-12 | SAI Parenterals LimitedTelangana | pHpH | CDL KolkataCDSCO lab |
| Iron Sucrose Injection USP 100 mg/5ml | 24RS06Mfg 2024-02 · Exp 2026-01 | SAI Parenterals LimitedTelangana | pH and AlkalinitypH | CDL KolkataCDSCO lab |
| Infusion Set (BMD) | BIV-020Mfg 2024-08 · Exp 2027-07 | Bhgwati Medicare DevicesGujarat | Test for SterilitySterility | State Lab KarnatakaState lab |
| Ibuprofen Tablets IP 400mg | TF240782Mfg 2024-06 · Exp 2026-08 | Orchid Medlife Pvt. LtdHimachal Pradesh | Sample does not conform to claim as per I.P. 2022 w.r.t. Dissolution of Ibuprofen.Dissolution | DTL BaddiState lab |
| ITRADEL-200k | SD6005CMfg 2023-06 · Exp 2025-05 | Sigma Softgel & Formulation plot no. 171Himachal Pradesh | The sample does not comply with IP requirements for Dissolution testDissolution | CDTL MumbaiCDSCO lab |
| Griseofulvin Tablets IP(GRISOVIK-250) | 8563Mfg 2024-05 · Exp 2026-04 | Vikram Laboratories (P) Ltd | On visual inspection, presence of spot was observed on tablets surface. The sample received does not conform with respect to the test for Description.Description | State Lab PuducherryState lab |
| Glypro 1 (Glimepiride Tablets IP) 1mg | FGYO-1626Mfg 2024-12 · Exp 2026-11 | Firstmed Therapeutics Pvt Ltd | Sample does not conform to IP specification for Glimepiride Tablets with respect to the content of GlimepirideOther | DTL MaduraiState lab |
| Glycical-B12 Calcium Phosphate, Vitamin D3 and Vitamin B12 Suspension | QL0606Mfg 2024-06 · Exp 2026-05 | Quest laboratories Pvt Ltd. Plot Nol 45 | All observations are done in Normal day light conditions with unaided eyes.18 �200 ml intact brown coloured plastic bottles received for analysis. Out of these18 �200 ml bottles, in 14 �200 ml bottles particles are stick around the neck of the bottle and cakes are distributed in the suspension and some cakes are floating on the top of the suspension. During Analysis when the content from these 14x200 ml bottles after shaking transferred individually in clean dry glass beaker, it is observed that, out of these14 � 200ml bottles, 11x200ml bottles contains white suspension with white, pale yellow, grey and black coloured cakes with some cakes floating on the top of suspension and 3x200ml bottle contain orange coloured suspension with white cakes with some cakes floating & on the top of suspension. Remaining 4x200ml bottle contains white suspension without cake and mix uniformly after shakingDescription | CDTL MumbaiCDSCO lab |
| Glycical-B12 Calcium Phosphate, Vitamin D3 and Vitamin B12 Suspension | QL0602Mfg 2024-06 · Exp 2026-05 | Quest laboratories Pvt Ltd. Plot Nol 45 | All observations are done in Normal day light conditions with unaided eyes.18 �200 ml intact brown coloured plastic bottles received for analysis. Out of these18 �200 ml bottles, in 5 �200 ml bottles particles are stick around the neck of the bottle and cakes are distributed in the suspension and some cakes are floating on the top of the suspension. During Analysis when the content from these 5x200 ml bottles after shaking transferred individually in clean dry glass beaker, it is observed that, all 5�200ml bottles, contains white suspension with white, pale yellow, grey and black coloured cakes with some cakes floating on the top of suspension out of remaining 13x200ml bottle 12�200ml bottle contains white suspension without cake and mixes uniformly after shaking and 1�200ml bottles contains orange coloured suspension without any cake and mix uniformly after shakingDescription | CDTL MumbaiCDSCO lab |
| Glimepiride Tablets I.P. 1 mg | 12801124Mfg 2024-08 · Exp 2026-07 | Karnataka Antibiotics & Pharmaceuticals Limited (A Govt of India Enterprise)Karnataka | "Related substances"Related substances | CDTL MumbaiCDSCO lab |
| Glimepiride Tablets (Glimilive ? 4) | MDP-649Mfg 2024-09 · Exp 2026-08 | Medinok healthcare Pvt. LtdPuducherry | Misbranded (1) For the received sample Glimepiride Tablets (Glimilive ? 4) , The label is mentioned as ?Approved colour used? but common name of the permitted colour used in the formulation as prescribed under rule 127(2) of the Drugs Rules ,1945 was not mentioned. (2) The sample received is labelled as Glimepiride Tablets (Glimilive ? 4) , however Glimepiride Tablets is an official IP monograph (2022) hence should be labelled as Glimepiride Tablets IPMisbranded | State Lab PuducherryState lab |
| Glimepiride 1 mg & Metformin HCl 500mg (Sustained Release) Tablets IP | SPT40298Mfg 2024-09 · Exp 2026-08 | Surge Pharmaceuticals Pvt. LtdMaharashtra | Test for Dissolution? and ?Assay for GlimeperideAssay | State Lab KarnatakaState lab |
| Gentamicin Injection IP (Gentatore Injection 80 mg/2ml) | IGMG418Mfg 2024-07 · Exp 2026-06 | Regain LaboratoriesHaryana | Particulate matter and DescriptionDescription | CDL KolkataCDSCO lab |
| Gentamicin Injection I.P- 2ml | 24BUH83Mfg 2024-08 · Exp 2026-07 | SVP Life SciencesUttarakhand | Sample does not conform to the requirement for pH.pH | King Institute ChennaiState lab |
| Gentamicin Injection I.P- 2ml | YGN4102Mfg 2024-07 · Exp 2026-06 | Yeluri formulations Pvt LtdTelangana | Sample does not conform to the requirement for pH.pH | King Institute ChennaiState lab |
| Gentamicin Inj. IP | D0003/25-26Mfg ? · Exp ? | Kerala Medical services Corporation LimitedKerala | It fails the test particulate matter and descriptive part for injectionsParticulate matter | DTL ThiruvananthapuramState lab |
| Frusemide Tablets IP 40mg | TA24283Mfg 2024-07 · Exp 2026-06 | Saintlife Pharmaceuticals LtdUttarakhand | Sample does not conform to IP specification for Frusemide Tablets with respect to DissolutionDissolution | DTL ChennaiState lab |
| Frusemide Injection IP- 2ml | 24BTC63Mfg 2024-03 · Exp 2026-02 | SVP Life SciencesUttarakhand | Sample does not conform to requirement for sterilitySterility | King Institute ChennaiState lab |
| Fluconazole Tablets I.P. 150 mg (Megmazole- 150 Tablets) | TSF-C0116Mfg 2024-01 · Exp 2025-12 | Spen Formulations Pvt. Ltd | Assay/Content of FluconazoleAssay | RDTL GuwahatiCDSCO lab |
| Fevimed (Paracetamol tablets IP 500 mg) | 451AA05Mfg 2023-12 · Exp 2025-11 | Sarv Pharmaceuticals Plot No. 28Uttarakhand | The Sample does not comply for description as the tablets shows light brown coloured spots on the surface of almost all the tabletsDescription | State Lab MaharashtraState lab |
| Fevimed (Paracetamol tablets IP 500 mg) | T-23204Mfg 2023-09 · Exp 2025-08 | Kshipra Drugs Pvt. Ltd. 40- 41/22B | The sample does not conform to standard quality in respect of the test for "Dissolution" performed.Dissolution | SDTL Agartala, TripuraState lab |
| Emiral OD Tablets, Ondansetron orally disintegrating Tablets IP | HT24565Mfg 2024-07 · Exp 2026-06 | Habitare Pharma Pvt Ltd Plot no. 43-44Haryana | Disintegration dose not complies as per IP.Disintegration | State Lab Drugs Control Laboratory, TelanganaState lab |
| Doxycycline Capsules IP 100 mg | B240705Mfg 2024-05 · Exp 2026-04 | Bochem Healthcare Pvt. Ltd | Dissolution of DoxycyclineDissolution | RDTL ChandigarhCDSCO lab |
| Diclofenac Sodium Tablets IP | THB24028ALMfg 2024-07 · Exp 2026-06 | Hindustan Laboratories LimitedMaharashtra | Sample does not conform to IP specification for Enteric Coated Tablets with respect to DisintegrationDisintegration | DTL ChennaiState lab |
| Defix -AZ | DP-240754Mfg 2024-09 · Exp 2026-08 | Park Pharmaceuticals 272Haryana | The sample fails in the test for Assay content of Cefixime & Azithromycin.Assay | DTL Srinagar (J&K)State lab |
| Cresol With Soap Solution (SPARK) (LYSOL IP) | J-Ly-213Mfg 2025-03 · Exp 2027-02 | Joe's TradersTamil Nadu | The sample received does not conform to above specification as per IP 2022 with respect to description.Description | State Lab PuducherryState lab |
| Compound Sodium Lactate Injection IP (RINGER-LACTATE SOLUTION FOR INJECTION ) (RL) | 1I245476Mfg 2024-09 · Exp 2027-08 | Aculife Healthcare Pvt. LtdGujarat | SterilitySterility | CDL KolkataCDSCO lab |
| Compound Sodium Lactate Injection I.P (Ringer Lactate Solution for injection I.P) (RL) | 4D40168Mfg 2024-10 · Exp 2027-09 | IHL Lifesciences Pvt. Ltd | Test for SterilitySterility | State Lab KarnatakaState lab |
| Clotrimazole and Selenium Sulfide Suspension, candid tv | 46230305Mfg 2023-12 · Exp 2025-11 | Glenmark Pharmaceuticals LtdUttarakhand | Sample does not conform to label claim with respect to identification and the content of clotrimazole (Deemed to be spurious)Identification | DTL MaduraiState lab |
| Clonazepam and Paroxetine Hydrochloride CR Tablets (Exotine CR) | 17671Mfg 2024-02 · Exp 2027-01 | Elikem Pharmaceuticals Pvt. Ltd | Uniformity of WeightUniformity of weight/content | State Drugs Laboratory, PunjabState lab |
| Ciprofloxacin Tablets IP 250 mg (Ciprodac 250) | CT24001Mfg 2024-02 · Exp 2027-01 | CADILA PHARMACEUTICALS LIMITEDGujarat | Dissolution" of CiprofloxacinDissolution | RDTL GuwahatiCDSCO lab |
| Ciprofloxacin Tablets IP 250 mg | CITB-02Mfg 2024-07 · Exp 2026-06 | NESTOR PHARMACEUTICALS LIMITEDHaryana | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Chlorpheniramine Maleate IP & Noscapine IP Oral Syrup (Coscopin Linctus) | VTL4006Mfg 2024-03 · Exp 2026-02 | Biological E LimitedTelangana | Sample does not conform to Label claim with respect to the content of NoscapineLabelling | DTL MaduraiState lab |
| Cetquine 5 Tablets (Levocetirizine Dihydrochlorine Tablets IP | ATX060546Mfg 2023-06 · Exp 2025-05 | ADWIN Pharma Vill RampurHimachal Pradesh | The sample does not comply with IP requirements for Dissolution test.Dissolution | CDTL MumbaiCDSCO lab |
| Ceftriaxone and Sulbactam for Injection IP (CEFRITZ S 1.5) | 24DH13VMfg 2024-08 · Exp 2026-07 | MMG HealthcareHimachal Pradesh | Bacterial endotoxins for Sterile water for Injection.Water content | CDL KolkataCDSCO lab |
| Cefpodoxime Proxetil Tablets I.P. 200 mg (BREPOD-200) | ST-25456Mfg 2024-10 · Exp 2026-09 | Sunvij Drugs Private LimitedGujarat | DissolutionDissolution | CDL KolkataCDSCO lab |
| Cefixime Tablets IP 400 mg | HTB404GMfg 2024-07 · Exp 2026-06 | Himalaya Meditek Pvt LtdUttarakhand | Sample does not conform to IP Specification for Cefixime Tablets with respect to the content of Anhydrous Cefixime in Cefixime Trihydrate.Other | DTL MaduraiState lab |
| Cefixime Oral Suspension IP Dry Syrup 30 ml | CADB- 02Mfg 2024-06 · Exp 2026-05 | Nestor Pharmaceuticals LimitedHaryana | It fails the test Assay, water and descriptive part for oral liquids as per IP , as specified in the Laboratory ProtocolAssay | DTL ThiruvananthapuramState lab |
| Cefixime & Potassium Clavulanate Tablets (Alfix-CV) | CT24117DMfg 2024-08 · Exp 2026-01 | Curehealth Pharmaceticals Pvt LtdHimachal Pradesh | Sample does not conform to label claim with respect to the content of Clavulanic Acid in Potassium Clavulanate.Labelling | DTL MaduraiState lab |
| Carboxymethyl Cellulose Sodium Eye Drops IP | MO24H27Mfg 2024-08 · Exp 2026-07 | Martin & Brown Bio- sciences Pvt. Ltd. K.no. 918/419 Malkumajra Nalagarh Road BaddiHimachal Pradesh | pH, Sterility and AssayAssay | CDL KolkataCDSCO lab |
| Carboxymethyl Cellulose Sodium Eye Drops IP | MO24H21Mfg 2024-08 · Exp 2026-07 | Martin & Brown Bio- sciences Pvt. Ltd. K.no. 918/419 Malkumajra Nalagarh Road BaddiHimachal Pradesh | pH, Sterility and AssayAssay | CDL KolkataCDSCO lab |
| Carboxymethyl Cellulose Sodium Eye Drops IP | MO24H22Mfg 2024-08 · Exp 2026-07 | Martin & Brown Bio- sciences Pvt. Ltd. K.no. 918/419 Malkumajra Nalagarh Road BaddiHimachal Pradesh | pH, Sterility and AssayAssay | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1292Mfg 2024-12 · Exp 2026-11 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1286Mfg 2024-12 · Exp 2026-11 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1298Mfg 2024-12 · Exp 2026-11 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1301Mfg 2024-12 · Exp 2026-11 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1302Mfg 2024-12 · Exp 2026-11 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1303Mfg 2024-12 · Exp 2026-11 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1304Mfg 2024-12 · Exp 2026-11 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1305Mfg 2024-12 · Exp 2026-11 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1306Mfg 2024-12 · Exp 2026-11 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1289Mfg 2024-12 · Exp 2026-11 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1294Mfg 2024-12 · Exp 2026-11 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1299Mfg 2024-12 · Exp 2026-11 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1300Mfg 2024-12 · Exp 2026-11 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium & Vitamin D3 Tablets IP (JKMSCL, Supply) | PGT24673Mfg 2024-09 · Exp 2026-08 | Affy Parenterals Vill Gullawala P.O. Baddi Distt Solan- 173205Himachal Pradesh | The sample does not conform to IP 2022 w.r.t Disintegration test for the sample portion receivedDisintegration | CFDL Jammu (J&K)State lab |
| Calcium & Vitamin D3 Tablets IP | QT23136Mfg 2024-11 · Exp 2026-10 | Quest Laboratories LimitedMadhya Pradesh | Dissolution (for Calcium) and Assay of Elemental CalciumAssay | CDL KolkataCDSCO lab |
| Burmoxicla+V(Amoxycill in & Potassium Clavulanate Oral Suspension IP) | ABD-187CMfg 2024-06 · Exp 2025-11 | Azot Life SciencesHimachal Pradesh | Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate oral suspension with Clavulanic Acid in Potassium Clavulanate respect to the content ofOther | DTL MaduraiState lab |
| Bupivacaine Hydrochloride Injection IP (Bupicain-0.5%) | BPC24007Mfg 2024-12 · Exp 2026-10 | Themis Medicare LimitedUttarakhand | Particulate matter and DescriptionDescription | CDL KolkataCDSCO lab |
| Bisacodyl Tablets Ip 5mg | TA24366Mfg 2023-06 · Exp 2026-04 | Saintlife Pharmaceuticals LtdUttarakhand | Sample does not conform to IP specification for Bisacodyl Tablets with respect to DissolutionDissolution | DTL ChennaiState lab |
| Bisacodyl Tablets IP 5mg | TA24688Mfg 2024-08 · Exp 2026-07 | Saintlife Pharmaceuticals LtdUttarakhand | Sample does not conform to IP specification for Bisacodyl Tablets with respect to Dissolution (Acid medium and Buffer medium)Dissolution | DTL ChennaiState lab |
| Bisacodyl Gastro- Resistant Tablets IP (Edilax) | 2418853T003Mfg 2024-06 · Exp 2027-05 | Scott-Edil Pharmacia LtdHimachal Pradesh | Does not comply with respect to test for DisintegrationDisintegration | State Lab PuducherryState lab |
| Betamethasone Valerate Ointment IP 0.1% w/w | B75Mfg 2024-08 · Exp 2026-07 | Syndicate PharmaMadhya Pradesh | Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone ValerateOther | DTL MaduraiState lab |
| Betamethasone Valerate Cream IP | E4062Mfg 2024-02 · Exp 2026-01 | Rhydburg Pharmaceuticals LtdUttarakhand | Sample does not conform to IP specification for Betamethasone Valerate Cream with respect to the content of Betamethasone in Betamethasone Valerate.Other | DTL MaduraiState lab |
| Atorvastatin Tablets IP 10mg | AT24045Mfg 2024-08 · Exp 2026-01 | Eurokem Laboratories Pvt ltd | Sample does not conform to IP specification for Atorvastatin Calcium Tablets with respect to DissolutionDissolution | DTL ChennaiState lab |
| Atorvastatin Tablets IP 10mg | CT240246AMfg 2024-07 · Exp 2026-06 | Candour PharmaceuticalsHimachal Pradesh | Sample does not conform to IP specification for Atorvastatin Calcium Tablets with respect to DissolutionDissolution | DTL ChennaiState lab |
| Atorvastatin Tablets IP 10mg | A297Mfg 2024-07 · Exp 2026-06 | Rikenbik PharmaTamil Nadu | Sample does not conform to IP specification for Atorvastatin Calcium Tablets with respect to DissolutionDissolution | DTL ChennaiState lab |
| Aspirin Gastro Resistant Tab IP 75 mg | ANET1235Mfg 2024-05 · Exp 2026-04 | Unicure India LtdUttar Pradesh | It fails the test ?Dissolution? Specified in the laboratory protocol as per IPDissolution | DTL ThiruvananthapuramState lab |
| Ampicillin Sodium Injection I.P. (AMPIVEE- 500 Injection) | TGDI082319 04Mfg 2023-08 · Exp 2025-07 | T & G MedicareHimachal Pradesh | SterillityOther | RDTL GuwahatiCDSCO lab |
| Amoxycillin and potassium clavulanate tablets IP 625 mg | BT240491Mfg 2024-05 · Exp 2026-04 | Hindustan Antibiotics LtdHimachal Pradesh | Sample does not conform to IP specification for amoxycillin and potassium clavulanate tablets with respect to the content of Clavulanic acid in potassium clavulanate.Other | DTL MaduraiState lab |
| Amoxycillin and potassium clavulanate tablets IP (AUGMONT CV 625 DUP Co- amoxiclav) | BT408244AMfg 2024-08 · Exp 2026-04 | Nikvin Healthcare (I) Pvt LtdHimachal Pradesh | Sample does not conform to IP specification for amoxycillin and potassium clavulanate tablets with respect to the content of Clavulanic acid in potassium clavulanate.Other | DTL MaduraiState lab |
| Amoxycillin & Potassium Calvulanate Tablets | BT406210AMfg 2024-06 · Exp 2026-05 | Nikvin Healthcare (I) Pvt LtdHimachal Pradesh | Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate Tablets with respect to Dissolution for Clavulanic Acid and to the content of Clavulanic Acid in Potassium Clavulanate DilutedDissolution | DTL ChennaiState lab |
| Amitriptyline HCl & Chlordiazepoxide Tablets USP (AMTOPIC-PLUS) | N2402062Mfg 2024-02 · Exp 2026-01 | Talent HealthcareUttarakhand | Assay for Amitriptyline onlyAssay | State Lab KarnatakaState lab |
| Amikacin Sulphate Injection I.P. 500 mg | 24AM18Mfg 2024-10 · Exp 2026-09 | SAI Parenterals LimitedTelangana | Particulate matter and DescriptionDescription | CDL KolkataCDSCO lab |
| Ambroxol Hydrochloride Syrup 30 mg/5 ml | 724559Mfg 2024-12 · Exp 2026-11 | Syndicate Pharma 185/BMadhya Pradesh | Misbranded The drug failed to indicate the common name of the colour, used in the drug, on the product label, as required under Rule 127(2) of the Drugs Rules, 1945. The label merely states Approved Colour Used. Hence, the drug is deemed to be Misbranded under Section 17 of the Drugs and Cosmetics Act, 1940, as it is not labeled in the prescribed manner.Misbranded | State Lab Drugs Control Laboratory, TelanganaState lab |
| Ambroxol Hydrochloride Syrup | 724543Mfg 2024-11 · Exp 2026-10 | By: Syndicate Pharma 185/BMadhya Pradesh | Misbranded The drug failed to indicate the common name of the colour, used in the drug, on the product label, as required under Rule 127(2) of the Drugs Rules, 1945. The label merely states Approved Colour Used. Hence, the drug is deemed to be Misbranded under Section 17 of the Drugs and Cosmetics Act, 1940, as it is not labeled in the prescribed manner.Misbranded | State Lab Drugs Control Laboratory, TelanganaState lab |
| Alograce Cream (Vitamin E, Honey & Aloevera Cream) | A2JJX048Mfg 2024-12 · Exp 2026-12 | RSH Global Pvt. LtdHimachal Pradesh | The sample does not conform to IS 6608:2004 for specifications of skin cream. It fails the test for ?Heavy metals (as lead) ppm? as specified in the laboratory protocolOther | DTL ThiruvananthapuramState lab |
| Albendazole Tablets IP 400 mg | T24/018AMfg 2024-12 · Exp 2026-11 | Samkem15-B & 10-BMadhya Pradesh | Dissolution dose not complies as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Albendazole Tablets IP 400 mg | T24/011AMfg 2024-12 · Exp 2026-11 | Samkem 15-B & 10- BMadhya Pradesh | Sample Does not comply in respect of Dissolution Test as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Albendazole Tablets IP 400 mg | LMT241100Mfg 2024-09 · Exp 2026-08 | Life Max Cancer Laboratories | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Albendazole Tablet IP 400 mg, | T24/007AMfg 2024-12 · Exp 2026-11 | Samkem 15-B & 10-BMadhya Pradesh | Dissolution does not comply as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Albendazole Tablet IP 400 mg, | T24/020AMfg 2024-12 · Exp 2026-11 | Samkem 15-B & 10-BMadhya Pradesh | Dissolution does not comply as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Albendazole Tablet IP 400 mg, | T24/016AMfg 2024-12 · Exp 2026-11 | Samkem 15-B & 10-BMadhya Pradesh | Dissolution does not comply as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Albendazole Tablet IP 400 mg, | T24/015AMfg 2024-12 · Exp 2025-11 | Samkem15-B & 10-BMadhya Pradesh | Dissolution does not comply as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Albendazole Tablet IP 400 mg, | C25F944019Mfg 2024-06 · Exp 2026-05 | Concept Pharmaceuticals Ltdm Khasra No. 104Uttarakhand | Dissolution dose not complies as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Albendazole Tablet IP 400 mg, | C25F944019Mfg 2024-06 · Exp 2026-05 | Concept Pharmaceuticals Ltdm Khasra No. 104Uttarakhand | Dissolution dose not complies as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Ahaglow Face Wash Gel 50 gm | AHA202Mfg 2024-05 · Exp 2026-04 | Torrent Pharmaceuticals LtdMadhya Pradesh | The sample does not conform to Cosmetics Rules 2020 for the standards of cosmetics. It fails the test for the content of ?Mercury? in finished cosmetic products as specified in the Laboratory Protocol.Other | DTL ThiruvananthapuramState lab |
| Adivasi Herbal Shampoo | MASH-23-101Mfg 2024-01 · Exp 2026-12 | Beauty Birds Cosmetics Bhatti CompoundGujarat | The sample does not comply with IS 7884:2004 specification for shampoo (Third Revision) reaffirmed 2019 requirements for microbial limitMicrobial limits | CDTL MumbaiCDSCO lab |
| Acremox-500 (Amoxycillin Trihydrate & Lactic Acid Bacillus Capsules) | ABC24002Mfg 2024-04 · Exp 2026-03 | Alexa PharmaceuticalsHimachal Pradesh | Assay for AmoxycillinAssay | State Lab KarnatakaState lab |
| Aceclofenac With Paracetamol Tablets (S-DOL-P) | MDP-018Mfg 2024-04 · Exp 2026-03 | Medinok Healthcare Pvt LtdPuducherry | Misbranded The label of the container in the drug is mentioned as "Approved colour used" but the common name of the permitted colour used in the formulation as prescribed under rule 127 (2) of the drug rule was not mentioned.Misbranded | State Lab PuducherryState lab |
| Aceclofenac & Paracetamol Tablets IP | GG204014Mfg 2024-04 · Exp 2026-03 | Innova Captab LimitedHimachal Pradesh | Misbranded Product is not official in I.P as on its manufacturing date mentioned on its label i.e. April 2024.Misbranded | State Drugs Laboratory, PunjabState lab |
| Aceclofenac & Paracetamol Tablets (Aceflam P) | T-2403035Mfg 2024-03 · Exp 2027-02 | Aagya Biotech Pvt LtdUttarakhand | On visual inspection, presence of spot was observed on tablets surface. The sample received does not conform as per IP 2022 with respect to Description.Description | State Lab PuducherryState lab |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Official sources and primary records
- Regulator
- Regulator
Changelog
- 20 Sep 2026: table generated from the CDSCO NSQ portal export (196 rows). Revised CDSCO lists are diffed on each monthly rebuild.